- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 17 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 6 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-FUC.6: 4 residues within 4Å:- Chain A: N.1094, T.1096, H.1097, F.1099
No protein-ligand interaction detected (PLIP)NAG-NAG-FUC.7: 1 residues within 4Å:- Chain A: N.1130
No protein-ligand interaction detected (PLIP)NAG-NAG-FUC.12: 5 residues within 4Å:- Chain B: N.1094, T.1096, H.1097, F.1099, P.1108
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:F.1099, B:P.1108
NAG-NAG-FUC.13: 1 residues within 4Å:- Chain B: N.1130
No protein-ligand interaction detected (PLIP)NAG-NAG-FUC.19: 3 residues within 4Å:- Chain C: N.1094, H.1097, F.1099
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:F.1099
NAG-NAG-FUC.20: 1 residues within 4Å:- Chain C: N.1130
No protein-ligand interaction detected (PLIP)- 24 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.24: 3 residues within 4Å:- Chain A: N.340, A.341, T.342
Ligand excluded by PLIPNAG.25: 2 residues within 4Å:- Chain A: N.599, T.600
Ligand excluded by PLIPNAG.26: 4 residues within 4Å:- Chain A: A.702, E.1068, K.1069, N.1070
Ligand excluded by PLIPNAG.27: 2 residues within 4Å:- Chain A: N.612, Q.640
Ligand excluded by PLIPNAG.28: 4 residues within 4Å:- Chain A: T.107, N.231, T.233
- Chain C: E.462
Ligand excluded by PLIPNAG.29: 3 residues within 4Å:- Chain A: Y.29, F.60, N.62
Ligand excluded by PLIPNAG.30: 5 residues within 4Å:- Chain A: N.121, T.123, F.126, E.152, E.154
Ligand excluded by PLIPNAG.31: 4 residues within 4Å:- Chain A: S.111, E.131, N.162, N.163
Ligand excluded by PLIPNAG.32: 3 residues within 4Å:- Chain A: N.351, R.352, T.353
Ligand excluded by PLIPNAG.33: 1 residues within 4Å:- Chain B: N.599
Ligand excluded by PLIPNAG.34: 4 residues within 4Å:- Chain B: A.702, E.1068, N.1070
- Chain C: Q.891
Ligand excluded by PLIPNAG.35: 2 residues within 4Å:- Chain B: G.229, N.231
Ligand excluded by PLIPNAG.36: 4 residues within 4Å:- Chain B: N.121, T.123, F.126, E.154
Ligand excluded by PLIPNAG.37: 2 residues within 4Å:- Chain B: Y.29, N.62
Ligand excluded by PLIPNAG.38: 3 residues within 4Å:- Chain B: N.328, Q.576, L.578
Ligand excluded by PLIPNAG.39: 2 residues within 4Å:- Chain B: N.340, F.368
Ligand excluded by PLIPNAG.40: 3 residues within 4Å:- Chain C: N.328, P.575, Q.576
Ligand excluded by PLIPNAG.41: 4 residues within 4Å:- Chain A: Q.832
- Chain C: N.612, T.614, Q.640
Ligand excluded by PLIPNAG.42: 4 residues within 4Å:- Chain B: E.462
- Chain C: T.107, N.231, T.233
Ligand excluded by PLIPNAG.43: 4 residues within 4Å:- Chain C: N.121, T.123, F.126, E.154
Ligand excluded by PLIPNAG.44: 3 residues within 4Å:- Chain C: E.131, N.162, N.163
Ligand excluded by PLIPNAG.45: 1 residues within 4Å:- Chain C: N.340
Ligand excluded by PLIPNAG.46: 2 residues within 4Å:- Chain C: N.599, T.600
Ligand excluded by PLIPNAG.47: 2 residues within 4Å:- Chain C: Y.29, N.62
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Windsor, I.W. et al., SARS-CoV-2 JN.1 and KP.2 spike characteristics and neutralization of JN.1-derived sublineages and T cell responses from mice immunized with monovalent JN.1- and KP.2-adapted BNT162b2 COVID-19 vaccines. To Be Published
- Release Date
- 2025-10-29
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 17 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 6 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 24 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Windsor, I.W. et al., SARS-CoV-2 JN.1 and KP.2 spike characteristics and neutralization of JN.1-derived sublineages and T cell responses from mice immunized with monovalent JN.1- and KP.2-adapted BNT162b2 COVID-19 vaccines. To Be Published
- Release Date
- 2025-10-29
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C